Education
About Us
Working with TipRanks
Follow Us
Biomaxima SA (DE:944)
:944
944 Stock Chart & Stats
Day’s Range― - ―
52-Week Range€2.12 - €3.18
Previous CloseN/A
Volume0.00
Average Volume (3M)16.00
Market Cap
€13.85M
Enterprise ValueN/A
Total Cash (Recent Filing)€576.00K
Total Debt (Recent Filing)€15.52M
Price to Earnings (P/E)56.8
Beta-0.24
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.03
Shares Outstanding4,193,118
10 Day Avg. Volume0
30 Day Avg. Volume16
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)0.00
Price to Sales (P/S)0.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
944 FAQ
What was Biomaxima SA’s price range in the past 12 months?
Biomaxima SA lowest stock price was €2.12 and its highest was €3.18 in the past 12 months.
What is Biomaxima SA’s market cap?
Biomaxima SA’s market cap is €13.85M.
When is Biomaxima SA’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Biomaxima SA’s earnings last quarter?
Currently, no data Available
Is Biomaxima SA overvalued?
According to Wall Street analysts Biomaxima SA’s price is currently Overvalued.
Does Biomaxima SA pay dividends?
Biomaxima SA does not currently pay dividends.
What is Biomaxima SA’s EPS estimate?
Biomaxima SA’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Biomaxima SA have?
Biomaxima SA has 4,193,118 shares outstanding.
What happened to Biomaxima SA’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Biomaxima SA?
Currently, no hedge funds are holding shares in DE:944
Company Description
Biomaxima SA
BioMaxima S.A. manufactures and distributes reagents for in vitro diagnostics in Poland. Its primary products include diagnostic reagents and analyzers for clinical chemistry; rapid tests and readers for detecting infectious diseases, cancer markers, cardiac markers, and drugs of abuse; urine analysis systems; hematology analyzers and reagents; ionselective analyzers and reagents; reagents and immunological analyzers of cardiac markers; glucometers for professional use; and analyzers for gasometric tests and critical blood parameters tests. The company also provides surfaces and air controls; antibiotics discs and MIC strips; and chromogenic, dehydrated, and prepared culture media; and additives and supplements for media. It supplies its products to approximately 2,000 laboratories in Poland, as well as exports in the international markets. BioMaxima S.A. was founded in 2002 and is based in Lublin, Poland.
Technical Analysis
Genomtec SA
―
Pure Biologics SA
―
Scope Fluidics SA
―
Biomed-Lublin Wytwornia Surowic i Szczepionek S.A.
―
Mabion SA
―